Our Advertisers Represent Some Of The Most Unique Products & Services On Earth!

 
rense.com

WHO Created Deadly
XDR-TB Strain - S African Scientists

By Adriana Stuijt
10-23-7

A uniquely-South African killer-strain of extensively drug- resistant tuberculosis (XDR-TB) was produced by the World Health Organization's distribution of anti-TB drugs without testing for drug resistance first, say South African scientists who have studied the strain for the past twelve years.
 
"The spread of a highly transmissible strain of drug-resistant tuberculosis has been facilitated by applying standard treatment regimens for susceptible and multi-drug resistant tuberculosis in the absence of drug resistance surveillance," said one of the authors, A. Willem Sturm, MD, of the University of KwaZulu-Natal School of Medicine in South Africa.
 
"Public health programs for the treatment and control of infectious diseases need to be supported by drug resistance surveillance programs."
 
In the beginning, this strain was resistant to several standard TB treatments; then, in 2001, South Africa adopted the WHO's standard strategy for fighting multi-drug resistant tuberculosis.
 
The strategy, known as DOTS-plus, recommends several so-called second line TB drugs -- but the strain was already becoming immune to these. Their study is published in the latest issue of the journal "Clinical Infectious Diseases"
 
The scientists say that testing for TB-drug resistance is expensive and time-consuming -- and while the WHO's strategy successfully delivered drugs, it didn't test for resistance.
 
"Within a few years, use of the recommended drugs left behind only those bacteria that could handle it. The strain then morphed from scary into a true nightmare." The researchers studied just one strain of so-called XDR-TB, but there are many out there, and they likely developed in the same way, they believe.
 
Tuberculosis drugs are desperately needed, they said-- but there might be an even greater need for drugs-resistance testing first.
 
Contact for original press release by the Infectious Diseases Society of America:
 
Steve Baragona - 703 299-0412
 
http://www.eurekalert.org/pub_releases/2007-10/idso-xti101907.php
Disclaimer
 







MainPage
http://www.rense.com


This Site Served by TheHostPros